Administrative Law: When a generic drug label fully carves out a patented use, are allegations that the generic drugmaker calls its product a "generic version" and cites public information about the branded drug enough to plead induced infringement of the patented use? - Argued: Wed, 29 Apr 2026 

USCA, First Circuit Bruno Project Rescue v. CDC, Case No. 25-1801

Audio Arguendo provides unedited recordings of oral arguments from the Supreme Court and interesting cases from around the globe. If you have a case that you think we should broadcast, just send us a tweet at @AudioArguendo with the name of the case, a short description of the issue, and a link to where the audio can be found. We assert no claim of copyright over any of the recordings and have posted them in podcast form to make them more widely and conveniently available.